Home
Storia in 8 fonti
FDA shuffles top drug, biologics leaders in latest shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
- ·
biopharmadive.com
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.
- ·
apnews.com
FDA chief's resignation widens a leadership gap at the nation's health department
Dr. Marty Makary's resignation from his post atop the Food and Drug Administration is widening a leadership gap that already existed at the U.S.
